A well-prepared IND application can help sponsors move more confidently toward clinical trials. However, preparation often involves coordinating regulatory, clinical, manufacturing, and nonclinical information across multiple teams. Missing or inconsistent information can make the review process more difficult. Early planning and regulatory input can help identify potential issues before submission. Read the complete article for key IND preparation considerations and learn how careful planning can reduce avoidable problems during the FDA review process. https://criterionedge.com/comm....on-problems-to-avoid
Like
Comment
Share
